Significantly elevated C-reactive protein serum levels are associated with very high 30-day mortality rates in hospitalized medical patients

Clinical Biochemistry

Volumn 43, Issue 13-14, 2010, Pages 1060-1063

  Chundadze, Tamar ^a   Steinvil, Arie ^b   Finn, Talya ^b   Saranga, Hila ^b   Guzner Gur, Hanan ^b   Berliner, Shlomo ^b   Justo, Dan ^b   Paran, Yael ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

C reactive protein; Mortality; Prognosis

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

ACUTE DISEASE; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BLOOD SAMPLING; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; DIABETES MELLITUS; DIAGNOSTIC KIT; DIFFERENTIAL DIAGNOSIS; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFECTION; ISCHEMIC HEART DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SERUM; STATISTICAL SIGNIFICANCE;

AGED; C-REACTIVE PROTEIN; CAUSE OF DEATH; DIAGNOSIS, DIFFERENTIAL; HOSPITAL MORTALITY; HUMANS; INFECTION; NEOPLASMS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 77956173924     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.06.006     Document Type: Article

References (12)

1. Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999, 340:448-454.
2. Vanderschueren S., Deeren D., Knockaert D.C., Bobbaers H., Bossuyt X., Peetermans W. Extremely elevated C-reactive protein. Eur J Intern Med 2006, 17:430-433.
3. Rogowski O., Vered Y., Shapira I., Hirsh M., Zakut V., Berliner S. Introducing the wide range C-reactive protein (wr-CRP) into clinical use for the detection of microinflammation. Clin Chim Acta 2005, 358:151-158.
4. Joffe E., Justo D., Mashav N., Swartzon M., Gur H., Berliner S., et al. C-reactive protein to distinguish pneumonia from acute decompensated heart failure. Clin Biochem 2004, 42:1628-1634.
5. Paran Y., Yablecovitch D., Choshen G., Zeitlin I., Rogowski O., Ben-Ami R., et al. C-reactive protein velocity to distinguish febrile bacterial infections from non-bacterial febrile illnesses in the emergency department. Crit Care 2009, 13:R50.
6. Justo D., Lachmi S., Saar N., Joffe E., Atzmony L., Mashav N., et al. C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia. Eur J Intern Med 2009, 20:518-521.
7. Smith R.P., Lipworth B.J. C-reactive protein in simple community-acquired pneumonia. Chest 1995, 107:1028-1031.
8. Lagerström F., Engfeldt P., Holmberg H. C-reactive protein in diagnosis of community-acquired pneumonia in adult patients in primary care. Scand J Infect Dis 2006, 38:964-969.
9. Lobo F.R., Bota D.P., Lopes-Ferreira F., Soliman H.M., Mélot C., Vincent J.L. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003, 123:2043-2049.
10. Cox M.L., Rudd A.G., Gallimore R., Hodkinson H.M., Pepys M.B. Real-time measurement of serum C-reactive protein in the management of infection in the elderly. Age Ageing 1986, 15:257-266.
11. Morley J.J., Kushner I. Serum C-reactive protein levels in disease. Ann NY Acad Sci 1982, 389:406-418.
12. Keshet R., Boursi B., Maoz R., Shnell M., Guzner-Gur H. Diagnostic and prognostic significance of serum C-reactive protein levels in patients admitted to the department of medicine. Am J Med Sci 2009, 337:248-255.